New autism cure research indicates how test drugs failed to be effective and how autism can be treated before it fully manifests. It's easy for parents to become discouraged when it comes to finding the cure for autism.
After all, autism is something that is very intricate and complicated to diagnose. According to TheAtlantic, recent autism cure research revealed that the drugs developed to counter autism failed due to having the "wrong design."
On top of that, inadequate tests led to these autism drugs to be rendered ineffective. Most drug companies that developed these types of drugs decided to halt drug development.
Due to multiple failed test results and poor drug designs, the companies would no longer risk investing in these drugs. Although some drug companies are giving their autism cures a reboot, such as the experimental fragile X syndrome drug Mavoglurant.
Autism Treatment Research Laboratory director Eric London attributed the failure of drug tests to the fact that these are mostly tested on a broad group of participants. Something that's not ideal in testing for autism and fragile x syndrome since these are considered as "heterogeneous" conditions.
Meanwhile, new autism cure research reveals that autism can be detected as early as an infant's first year. According to USAToday, researchers now use brain scans that can detect if a child has signs of autism, way before symptoms manifest.
Previously, a child would have to be at least four years old before he/she is diagnosed for autism. However, the recent autism cure research shows that symptoms of autism can now be pinpointed with an accuracy of 80 percent as early as one year old.
This way, autism can be targeted before it manifests in the infant, which can drastically affect the child's outcome. Despite this advancement in autism cure research, the source stated that more research is required before autism MRI scans become a standard.
